ArticleGE Portuguese journal of gastroenterology
Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block.
Article in GE Portuguese journal of gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 24 citations in OpenAlex.
- Olmesartan-associated enteropathy presenting with metabolic acidosis and acute kidney injury requiring hemodialysis: a rechallenge-confirmed case.CEN case reports · 2026Article
- Use of Angiotensin Receptor Blockers in Celiac Disease Associated with Worse Outcomes.Digestive diseases and sciences · 2025Article
- A Rare Case of Olmesartan-Associated Enteropathy Successfully Managed With Steroid Taper.Cureus · 2023Article
- Olmesartan-associated Enteropathy with Acute Kidney Injury.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2022Article
- A Case Report of Olmesartan-Induced Enteropathy.Cureus · 2021Article
- Article
- Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.The American journal of case reports · 2019Article
- Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea.European journal of case reports in internal medicine · 2019Article
- Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report.Current drug safety · 2019Article
- Olmesartan-associated enteropathy.Proceedings (Baylor University. Medical Center) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.